Kusajili – Clinical trials directory

Result of your search per sponsor: Sanofi-Synthelabo Recherche, a subsidiary of sanofi-aventis group

Woman Max 99 years
Sanofi-Synthelabo Recherche, a subsidiary of sanofi-aventis group Update Il y a 4 ans

A Multicenter, Open-Label, Single-Arm Study of Intravenous AVE0005 VEGF Trap Administered Every 2 Weeks in Advanced Ovarian Cancer Patients with Recurrent Symptomatic Malignant Ascites Estimate the repeat paracentesis response rate RPRR in advanced ovarian cancer patients with recurrent symptomatic malignant ascites

Country None
organs None
Specialty None

Closed trial

More information